PAPER Rasovska H, Rektorova I
SEARCH RESULTS
330988 RESULTS
PAPER Trachtenberg AJ, Filippini N, Ebmeier KP, Smith SM, Karpe F, Mackay CE
The effects of APOE on the functional architecture of the resting brain.
Neuroimage. 2012 Jan 2;59(1):565-72. Epub 2011 Aug 7 PubMed: 21851856PAPER Ge R, Sun X
The in vivo functions of a histidine-rich protein Hpn in Helicobacter pylori: linking gastric and Alzheimer's diseases together?
Med Hypotheses. 2011 Nov;77(5):788-90. PubMed: 21852052PAPER Karran E, Mercken M, De Strooper B
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.
Nat Rev Drug Discov. 2011 Sep;10(9):698-712. PubMed: 21852788PAPER Marin R
Signalosomes in the brain: relevance in the development of certain neuropathologies such as Alzheimer's disease.
Front Physiol. 2011;2:23. PubMed: 21852974PAPER Santillo AF, Gambini JP, Lannfelt L, Långström B, Ulla-Marja L, Kilander L, Engler H
In vivo imaging of astrocytosis in Alzheimer's disease: an ¹¹C-L-deuteriodeprenyl and PIB PET study.
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2202-8. PubMed: 21853308PAPER Mendelsohn AR, Larrick JW
Rapamycin as an antiaging therapeutic?: targeting mammalian target of rapamycin to treat Hutchinson-Gilford progeria and neurodegenerative diseases.
Rejuvenation Res. 2011 Aug;14(4):437-41. PubMed: 21851176PAPER Stieren ES, El Ayadi A, Xiao Y, Siller E, Landsverk ML, Oberhauser AF, Barral JM, Boehning D
Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein.
J Biol Chem. 2011 Oct 14;286(41):35689-98. PubMed: 21852239PAPER Venturelli M, Scarsini R, Schena F
Six-month walking program changes cognitive and ADL performance in patients with Alzheimer.
Am J Alzheimers Dis Other Demen. 2011 Aug;26(5):381-8. PubMed: 21852281Qiliu Peng
Guangxi Medical UniversityChina
PAPER Tu T, Tu AT, Lin TS